Accession Number: | 0001209191-20-011784 |
Date: | 2020-02-19 |
Issuer: | CHEMOCENTRYX, INC. (CCXI) |
Original Submission Date: |
KANAYA SUSAN M
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW, CA 94043
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-02-19 | M | 24,200 | a | $10.86 | 118,380 | indirect | ||
COMMON STOCK | 2020-02-19 | S | 21,000 | d | $50.06 | 97,380 | indirect | ||
COMMON STOCK | 2020-02-19 | S | 3,200 | d | $50.63 | 94,180 | indirect | ||
COMMON STOCK | 2020-02-19 | 0 | $0.00 | 91,317 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 10.86 | 2020-02-19 | deemed execution date | M | 24,200 (d) | 2028-03-05 | common stock 24,200 | $10.86 | 55,000 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | reflects the weighted average sale price of the sales sold. the shares were sold in multiple trades at prices ranging from $49.51 to $50.44 per share. the reporting person will provide to the sec staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
f3 | reflects the weighted average sale price of the sales sold. the shares were sold in multiple trades at prices ranging from $50.51 to $50.75 per share. the reporting person will provide to the sec staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
f4 | as of february 19, 2020, and prior to this transaction, the exercised options were fully vested. |
f5 | not applicable. |